Metastatic prolactinoma: Effect of octreotide, cabergoline, carboplatin and etoposide; immunocytochemical analysis of proto-oncogene expression

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 9, 1997, Pages 2962-2965

  Hurel, Steven J ^a   Harris, Philip E ^b   Mcnicol, Anne Marie ^d   Foster, Sally ^a   Kelly, William F ^c   Baylis, Peter H ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; CARBOPLATIN; ETOPOSIDE; OCTREOTIDE; PROLACTIN; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; FACE PAIN; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; METASTASIS; ONCOGENE C MYC; PRIORITY JOURNAL; PROLACTINOMA; PROTO ONCOGENE; SUBCUTANEOUS DRUG ADMINISTRATION;

POMACANTHUS MACULOSUS;

EID: 0030930620     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.9.4217     Document Type: Article

References (23)

1. Walker JD, Grossman A, Anderson JV, et al. 1993 Malignant prolactinoma with extracranial metastases: a report of three cases. Clin Endocrinol (Oxf). 38:411-419.
2. Davies JRE, Sheppard MC, Heath DA. 1990 Giant invasive prolactinoma: a case report and review of nine other cases. 1990 Q J Med. 74:227-238.
3. Assies J, Verhoeff NPLG, Bosch D, Hofland LJ. 1993 Intracranial dissemination of a macroprolactinoma. Clin Endocrinol (Oxf). 38:539-546.
4. Levy A, Lightman SL. 1993 The pathogenesis of pituitary adenomas. Clin Endocrinol (Oxf). 38:559-570.
5. Landis, CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. 1989 GTPase inhibiting mutations activate the a chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature. 340:692-696.
6. Vallar L, Spada A, Giannattasio G. 1987 Altered Gs and adenylate cyclase activity in human growth hormone-secreting pituitary adenomas. Nature. 330:566-568.
7. 2α mutations in clinically non-functioning pituitary tumours. Clin Endocrinol (Oxf). 41:815-820.
8. Williamson EA, Ince PG, Harrison D, Kendall-Taylor P, Harris PE. 1995 G protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas. Eur J Clin Invest. 25:128-131.
9. Karga HJ, Alexander JM, Hedley-Whyte ET, Klibanski A, Jameson JL. 1992 Ras mutations in human pituitary tumours. J Clin Endocrinol Metab. 74:914-919.
10. Pei L, Melmed S, Scheithauer B, Kovacs K, Prager D. 1994 H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab. 28:842-846.
11. Alvaro V, Levy L, Dubray C, et al. 1993 Invasive human pituitary tumours express a point-mutated α-protein kinase-C. J Clin Endocrinol Metab. 77:1125-1129.
12. Levy A, Hall L, Yeudall A, Lightman SL. 1994 p53 gene mutations in pituitary adenomas: rare events. Clin Endocrinol (Oxf). 41:809-814.
13. Buckley N, Bates AS, Broome JC, et al. 1994 p53 protein accumulates in Cushings adenomas and invasive non-functional adenomas. J Clin Endocrinol Metab. 79:1513-1516.
14. Woloschak M, Roberts JL, Post K. 1994 c-Myc, c-fos, and c-myb gene expression in human pituitary adenomas. J Clin Endocrinol Metab. 79:25713-25714.
15. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager, D. 1995 Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res. 55:1613-1616.
16. Ekbom K. 1983 Der prãesenile Dermatozoenwahn. Acta Psychiatr Neurol Scand. 13:227-229.
17. de Bruin TWA, Kwekkeboom DJ, Van't Verlaat JW. 1992 Clinically non-functioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro. J Clin Endocrinol Metab. 75:1310-1317.
18. Yin KJ. 1995 Distribution of somatostatin mRNA containing neurons in the primary pain relaying nuclei of the rat. Anat Rec. 241:579-584.
19. Duggan AW. 1992 Neuropharmacology of pain. Curr Opin Neurol Neurosurg. 5:503-507.
20. Silveri F, Morosini P, Breciaroldi D, Cervini C. 1994 Infra-articular injection of somatostatin in knee osteoarthritis: clinical results and IGF-1 serum levels. Int J Clin Pharmacol Res. 14:79-85.
21. Herman V, Fagin J, Gonsky E, Erzin C, Kovacs K. 1990 Clonal origins of pituitary adenomas. J Clin Endocrinol Metab. 71:1427-1433.
22. Brada M, Rajan B, Traish D, et al. 1993 The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf). 38:571-578.
23. Brada M, Ford D, Ashley S, et al. 1992 Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. Br Med J. 304: 1343-1346.